Multifocals: Careful pre-op preparation minimises explantation

Article

Careful patient selection and precise biometry will all help minimise the risk of later explantation of multifocal IOLs.

Careful patient selection and precise biometry will all help minimise the risk of later explantation of multifocal IOLs, Dr Risto Uusitalo of the Helsinki Eye Clinic said.

"There is a stacking effect, where a number of small errors stack up into a large error. That is why it is vital to get precise biometry, and select appropriate patients," explained Dr Uusitalo.

Exclusion criteria include astigmatism greater than 1.0 D, pre-existing ocular pathology, such as very dense cataract where you can't see the fundus properly, and previous refractive procedure. Physical data is not enough, assessing the psychological profile is also vital.

"A teacher once told me, if your patient has more than three pens in his pocket, be careful. They are typically physicians, architects, engineers and artists. They are perfectionists, they have unrealistic expectations and they are less likely to be happy with loss in vision quality," Dr Uusitalo said.

Similarly, professions that depend on the quality of vision should be excluded too, for example truck drivers.

Dr Uusitalo concluded that multifocal IOLs pose some risks that cannot be ignored, these can, however, be reduced and, overall, the benefits outweigh the risk, for the right patient.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.